As of the latest Form 4 filed Jul 2, 2026.
What Ardent Health Partners, Inc. insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 32 most recent filings for ARDT.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-02 | 2026-07-01 | Caspers Dave CEO and President | AAward | +104K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-05 | DeMichiei Robert Director | PPurchase | +11.3K | $8.73 | $98.3K | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-05 | LUMSDAINE ALFRED Chief Financial Officer | PPurchase | +10.0K | $8.81 | $88.1K | No | Form 4 ↗ |
| 2026-04-02 | 2026-04-01 | Bulgarelli Peter J. Director | AAward | +14.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-02 | 2026-04-01 | Havdala Ellen Director | AAward | +14.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-02 | 2026-04-01 | Sotir Mark R Director | AAward | +14.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-02 | 2026-04-01 | Sen Rahul Director | AAward | +14.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-02 | 2026-04-01 | Webb Robert Thomas Director | AAward | +14.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-02 | 2026-04-01 | Robinson Edmondo Director | AAward | +14.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-02 | 2026-04-01 | DeMichiei Robert Director | AAward | +14.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-02 | 2026-04-01 | GOODYEAR WILLIAM M Director | AAward | +14.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-02 | 2026-04-01 | Campion Suzanne Director | AAward | +14.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-02 | 2026-04-01 | BYNOE PETER C B Director | AAward | +14.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-02 | 2026-04-01 | Caspers Dave Chief Operating Officer | AAward | +35.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-02 | 2026-04-01 | Caspers Dave, Chief Operating Officer | FTax | −2.68K | $8.67 | $23.3K | No | Form 4 ↗ |
| 2026-04-02 | 2026-04-01 | Petrovich Stephen C. EVP, GC and Secretary | AAward | +24.9K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-02 | 2026-04-01 | Petrovich Stephen C., EVP, GC and Secretary | FTax | −1.81K | $8.67 | $15.7K | No | Form 4 ↗ |
| 2026-04-02 | 2026-04-01 | Byers David Raynor SVP & Chief Accounting Officer | AAward | +11.5K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-02 | 2026-04-01 | Byers David Raynor, SVP & Chief Accounting Officer | FTax | −924.00 | $8.67 | $8.01K | No | Form 4 ↗ |
| 2026-04-02 | 2026-04-01 | LUMSDAINE ALFRED Chief Financial Officer | AAward | +53.8K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-02 | 2026-04-01 | LUMSDAINE ALFRED, Chief Financial Officer | FTax | −4.38K | $8.67 | $38.0K | No | Form 4 ↗ |
| 2026-04-02 | 2026-04-01 | Bonick Martin President and CEO | AAward | +135K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-02 | 2026-04-01 | Bonick Martin, President and CEO | FTax | −11.0K | $8.67 | $95.0K | No | Form 4 ↗ |
| 2026-04-02 | 2026-03-31 | Petrovich Stephen C. EVP, GC and Secretary | FTax | −1.43K | $8.56 | $12.2K | No | Form 4 ↗ |
| 2026-04-02 | 2026-03-31 | Byers David Raynor SVP & Chief Accounting Officer | FTax | −819.00 | $8.56 | $7.01K | No | Form 4 ↗ |
| 2026-04-02 | 2026-03-31 | LUMSDAINE ALFRED Chief Financial Officer | FTax | −2.51K | $8.56 | $21.5K | No | Form 4 ↗ |
| 2026-04-02 | 2026-03-31 | Bonick Martin President and CEO | FTax | −8.03K | $8.56 | $68.7K | No | Form 4 ↗ |
| 2026-03-13 | 2026-03-11 | Petrovich Stephen C. EVP, GC and Secretary | AAward | +34.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-13 | 2026-03-11 | LUMSDAINE ALFRED Chief Financial Officer | AAward | +61.1K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-13 | 2026-03-11 | Chernin Ethan President of Health Services | AAward | +32.4K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-13 | 2026-03-11 | Bonick Martin President and CEO | AAward | +195K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-13 | 2026-03-11 | Byers David Raynor SVP & Chief Accounting Officer | AAward | +8.86K | $0.00 | $0.00 | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also ARDT’s full analysis or the market-wide insider trading feed. The tabs above jump to ARDT’s other SEC data.
Source: SEC Form 4 filings for ARDT, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.